03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Clavodar Tablets 1g* : | |
Type | Medicine Non Marketed |
Originator | Augmentin BD Tablets |
Agent | Sadco |
Distributor | Sadco |
Laboratory | Dar Al Dawa |
Responsible Party | Dar Al Dawa |
Origin | Jordan |
Manufacturer | Dar Al Dawa Development & Investment |
Manufacturing Type | G |
Origin | Jordan |
ATC | J01CR02 |
Clavodar Tablets 1g* :
Clavodar Tablets 1g* :
Clavodar Tablets 1g* :
Clavodar Tablets 1g* :
Clavodar Tablets 1g* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Acute generalised exanthematous pustulosis (AGEP) | Not known |
Agranulocytosis | Not known |
ALT increased | Uncommon |
Anaphylaxis | Not known |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
Antibiotic associated colitis | Not known |
AST increased | Uncommon |
Black hairy tongue | Not known |
Bleeding time prolonged | Not known |
Cephalea | Uncommon |
Convulsion | Not known |
Crystalluria | Not known |
Dermatitis bullous | Not known |
Dermatitis exfoliative | Not known |
Diarrhoea (Diarrhea) | Very Common |
Erythema multiforme | Rare |
Haemolytic anemia | Not known |
Hepatitis | Not known |
Hyperactivity (Increased activity) | Not known |
Indigestion | Uncommon |
Interstitial nephritis | Not known |
Jaundice cholestatic (Cholestatic icterus) | Not known |
Leucopenia (Leukopenia) | Rare |
Lightheadedness | Uncommon |
Meningitis aseptic | Not known |
Mucocutaneous candidiasis | Common |
Nausea | Common |
Necrolysis epidermal | Not known |
Neutropenia | Rare |
Overgrowth of non-susceptible organisms | Not known |
Pruritus | Uncommon |
Quick's value increased | Not known |
Serum sickness | Not known |
Skin Eruption | Uncommon |
Stevens-Johnson syndrome | Not known |
Thrombocytopenia (Thrombopenia) | Rare |
Urticaria | Uncommon |
Vasculitides | Not known |
Vomiting | Common |
Clavodar Tablets 1g* :
NB : Products With Same Indication |
Different Units By MoH Code
Clavodar Tablets 1g* MoH 5747 :
Form | Tablet, Film-Coated |
Packaging | Plastic Bottle |
Package Size | Box of 14 |
Strength | 1g |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 221988/09 |
Submission date | 01/01/2009 |
Registration Year | 2010 |
Archived Date | 03/09/2021 |
Barcode | 6251107241016 |
Price Comparison
● Country: | Qatar | |
● Package Size: | 14 | |
● Public Price: | 71 QAR | ( 1,743,618.00 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 5,0714 QAR | ( 122,790.00 LBP ) |
● Pharmacy Price: | 58.4241575398 QAR | ( 1434780.4608624 LBP ) |
● Pricing Date: | 28/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Abu Dhabi | |
● Package Size: | 14 | |
● Public Price: | 60.5 AED | ( 1,461,740.50 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 4,3214 AED | ( 96,644.00 LBP ) |
● Pharmacy Price: | 48.88 AED | ( 1180989.68 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UAE | |
● Package Size: | 14's (7's Blister x 2) | |
● Public Price: | 60.5 AED | ( 1,461,740.50 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 4,3214 AED | ( 96,644.00 LBP ) |
● Pharmacy Price: | 48.88 AED | ( 1180989.68 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 14 | |
● Public Price: | 26.3 SAR | ( 621,732.00 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 1,8786 SAR | ( 23,640.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Oman | |
● Package Size: | 14 | |
● Public Price: | 4.81 OMR | ( 1,109,830.54 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 0,3436 OMR | ( 0.00 LBP ) |
● Pricing Date: | 19/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Jordan | |
● Package Size: | 14 | |
● Public Price: | 12.9 JOD | ( 1,615,350.90 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 0,9214 JOD | ( 0.00 LBP ) |
● Pharmacy Price: | 9.84 JOD | ( 1232174.64 LBP ) |
● Reference: | JFDA | |
● Pricing Date: | 02/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Bahrain | |
● Package Size: | 14 | |
● Public Price: | 5.58 BHD | ( 1,326,555.72 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 0,3986 BHD | ( 0.00 LBP ) |
● Reference: | nhra | |
● Pricing Date: | 09/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Kuweit | |
● Package Size: | Boîte de 14 | |
● Public Price: | 4.52 KWD | ( 1,326,986.12 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 0,3229 KWD | ( 0.00 LBP ) |
● Pharmacy Price: | 3.82 KWD | ( 1121479.42 LBP ) |
● Pricing Date: | 07/02/2021 | |
● Type: | Medicine Authorised |
Note
You have to register to view this info
Drop File